An interventional study of exercise in Exercise Therapy, sponsored by Universidad Europea de Madrid. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-07-19.
Sponsored by Universidad Europea de Madrid · Not applicable, Interventional, and Treatment
The purpose of this RCT is to study the effects of whole muscle training (inspiratory muscle training + aerobic training + muscle resistance training) on muscle power, VO2peak and gas-exchange variables obtained during cardiopulmonary exercise testing, QoL, functional capacity (eg, 6-min walking distance), and maximal inspiratory pressure in patients with pulmonary artery hypertension.
1,105 studies on the registry are indexed under Hypertension, Pulmonary; 234 are open to participants now.
This study's enrollment of 40 is above the median of 35 across 649 interventional studies indexed under Hypertension, Pulmonary.
Browse Hypertension, Pulmonary studies →Universidad Europea de Madrid is the lead sponsor of 94 studies on the registry; 22 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
exercise intervention during 8 weeks
Other: exercise
Exercise training for 8 weeks (aerobic exercise, resistance training and inspiratory muscle training thrice a week)
Muscle power (upper and lower-body)
Time frame: 8 weeks
6 minute walk distance test
Time frame: 8 weeks
maximal inspiratory pressure (PImax)
Time frame: 8 weeks
Short Form 36-Item Health Survey questionnaire version 2 (SF-36)
Time frame: 8 weeks
Physical activity levels objectively determined with accelerometry
Time frame: 8 weeks
Peak oxygen uptake (VO2peak) directly measured during cardiopulmonary exercise testing (CEPT)
Time frame: 8 weeks
Other CEPT variables
Gas-exchange variables at the anaerobic threshold
Time frame: 8 weeks
NT-ProBNP
Time frame: 8 weeks
Performance in the 5-repetition sit-stand-test (5SST)
Time frame: 8 weeks
Safety assessment
Evaluation of adverse episodes, ie. syncopal/pre-syncopal episodes, severe dyspnea, arrhythmias, asthma, signs of poor peripheral perfusion or central nervous symptoms (ataxia, tremors). These episodes were be reported directly by the study researchers (in the exercise group) and by a telephone interview every 2 weeks in all participants.
Time frame: 8 weeks
This study is completed, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad Europea de Madrid